52159-49-6

Basic information

• Product Name: {[(2Z)-4-chlorobut-2-en-1-yl]oxy}benzene
• CAS NO: 52159-49-6
• Molecular Formula: C₁₀H₁₁ClO
• Molecular Weight: 182.6467
• Mol File: 52159-49-6.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 285.9°C at 760 mmHg
• Flash Point: 129.3°C
• Density: 1.087g/cm³
• Vapor Pressure: 0.00471mmHg at 25°C
• Refractive Index: 1.528
• CAS DataBase Reference: {[(2Z)-4-chlorobut-2-en-1-yl]oxy}benzene(CAS DataBase Reference)
• NIST Chemistry Reference: {[(2Z)-4-chlorobut-2-en-1-yl]oxy}benzene(52159-49-6)
• EPA Substance Registry System: {[(2Z)-4-chlorobut-2-en-1-yl]oxy}benzene(52159-49-6)

Safety Data

• Hazardous Substances Data: 52159-49-6(Hazardous Substances Data)

Usage

General Description

{[(2Z)-4-chlorobut-2-en-1-yl]oxy}benzene is a chemical compound with the molecular formula C10H11ClO. It is a member of the class of compounds known as benzene and substituted derivatives. {[(2Z)-4-chlorobut-2-en-1-yl]oxy}benzene is also known by the name 1-[(2Z)-4-chloro-2-buten-1-yl]oxybenzene. It consists of a benzene ring substituted with a 4-chloro-2-buten-1-yl group. {[(2Z)-4-chlorobut-2-en-1-yl]oxy}benzene is commonly used in the production of organic compounds and in chemical research as a reagent. It has a variety of industrial applications, and its structure and properties make it useful in the synthesis of other organic compounds.

Upstream product

• 1476-11-5 Z-1,4-dichlorobutene 
• 584-08-7 potassium carbonate 
• 108-95-2 phenol 
• 110-57-6 trans-1,4-dichlorobut-2-ene 
• 764-41-0 1,4-dichloro-2-butene 
• 139-02-6 sodium phenoxide 

Downstream Products

• 82259-82-3 methyl 2-pentyl-3-oxo-8-phenoxy-6-octenoate 

Relevant articles and documents

4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists

PCT No. PCT/US96/20872 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Dec. 20, 1996 PCT Pub. No. WO97/23216 PCT Pub. Date Jul. 3, 1997Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs are selective active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, psychosis, anxiety, migraine headaches, glaucoma, CMV retinitis, aminoglycoside antibiotics-induced hearing loss, convulsions, chronic pain, opioid tolerance or withdrawal, urinary incontinence or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described.